Parametric Portfolio Associates’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$304K Buy
150,446
+33,552
+29% +$65.9K ﹤0.01% 3270
2021
Q4
$317K Buy
116,894
+20,674
+21% +$76.4K ﹤0.01% 3264
2021
Q3
$429K Buy
96,220
+5,384
+6% +$25.9K ﹤0.01% 3167
2021
Q2
$527K Buy
90,836
+14,658
+19% +$85.9K ﹤0.01% 3063
2021
Q1
$535K Buy
76,178
+33,203
+77% +$223K ﹤0.01% 3476
2020
Q4
$206K Buy
42,975
+12,443
+41% +$62.9K ﹤0.01% 3762
2020
Q3
$178K Sell
30,532
-70,810
-70% -$424K ﹤0.01% 3694
2020
Q2
$684K Buy
101,342
+66,376
+190% +$503K ﹤0.01% 3115
2020
Q1
$222K Buy
34,966
+2,566
+8% +$20.6K ﹤0.01% 3512
2019
Q4
$338K Buy
+32,400
New +$236K ﹤0.01% 3525
2019
Q3
Sell
-30,110
Closed -$448K 4025
2019
Q2
$448K Sell
30,110
-38,787
-56% -$701K ﹤0.01% 3406
2019
Q1
$1.71M Buy
68,897
+17,231
+33% +$432K ﹤0.01% 2743
2018
Q4
$928K Sell
51,666
-7,987
-13% -$163K ﹤0.01% 3031
2018
Q3
$1.75M Buy
59,653
+25,623
+75% +$992K ﹤0.01% 2804
2018
Q2
$1.55M Sell
34,030
-1,726
-5% -$83.9K ﹤0.01% 2835
2018
Q1
$1.89M Buy
35,756
+4,421
+14% +$258K ﹤0.01% 2660
2017
Q4
$2.13M Sell
31,335
-16,096
-34% -$1.13M ﹤0.01% 2564
2017
Q3
$3.91M Sell
47,431
-7,595
-14% -$602K ﹤0.01% 2066
2017
Q2
$5.15M Sell
55,026
-7,432
-12% -$455K 0.01% 1748
2017
Q1
$3.98M Buy
62,458
+37,237
+148% +$2.26M 0.01% 1956
2016
Q4
$1.12M Buy
25,221
+13,384
+113% +$471K ﹤0.01% 2768
2016
Q3
$427K Buy
11,837
+1,376
+13% +$29.5K ﹤0.01% 3244
2016
Q2
$144K Buy
+10,461
New +$153K ﹤0.01% 3677
2016
Q1
Sell
-6,498
Closed -$227K 4052
2015
Q4
$227K Sell
6,498
-13,169
-67% -$849K ﹤0.01% 3682
2015
Q3
$1.81M Buy
19,667
+2,196
+13% +$190K ﹤0.01% 1923
2015
Q2
$1.53M Sell
17,471
-827
-5% -$70.8K ﹤0.01% 2456
2015
Q1
$1.36M Sell
18,298
-2,558
-12% -$181K ﹤0.01% 2544
2014
Q4
$1.17M Buy
20,856
+478
+2% +$25.1K ﹤0.01% 2657
2014
Q3
$924K Buy
20,378
+8,984
+79% +$375K ﹤0.01% 2763
2014
Q2
$472K Sell
11,394
-7,506
-40% -$387K ﹤0.01% 3238
2014
Q1
$1.31M Buy
18,900
+1,042
+6% +$76.5K ﹤0.01% 2440
2013
Q4
$1.08M Buy
17,858
+7,050
+65% +$383K ﹤0.01% 2600
2013
Q3
$657K Buy
10,808
+6,496
+151% +$461K ﹤0.01% 2912
2013
Q2
$289K Buy
+4,312
New +$194K ﹤0.01% 3295

Other funds holding CLVS